INDOMETHACIN CH indometacin (as sodium trihydrate) 1mg powder for injection vial

Active ingredient:

indometacin sodium trihydrate, Quantity: 1.061 mg (Equivalent: indometacin, Qty 1 mg)

Available from:

MedTAS Pty Ltd

INN (International Name):

indometacin sodium trihydrate

Pharmaceutical form:

Injection, powder for

Composition:

Excipient Ingredients:

Administration route:

Intravenous

Units in package:

3 vials

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

INDOMETHACIN CH is indicated for the closure of patent ductus arteriosus in premature babies. Clear-cut clinical evidence of a haemodynamically significant patent ductus arteriosus should be present, such as respiratory distress, a continuous murmur, a hyperactive precordium, cardiomegaly and pulmonary plethora on chest x-ray. This product should only be used in a hospital under supervision of a specialist neonatologist.

Product summary:

Visual Identification: Indomethacin for Injection 1 mg/vial is a white to yellow lyophilized powder (or plug); Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2014-04-02